• 1
    Mayer TG, Gatchel RJ, Polatin PB, eds. Occupational Musculoskeletal Disorders: Function, Outcomes and Evidence Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
  • 2
    Nedeljkovic SS, Wasan A, Jamison RN. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain. 2002;18:S39S51.
  • 3
    Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372380.
  • 4
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders , 4th ed. Washington, DC: APA; 1994.
  • 5
    Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18:S28S38.
  • 6
    Liaison Committee on Pain and Addiction. Definitions related to the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine, 2001.
  • 7
    Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203217.
  • 8
    Zacny J, Bigelow G, Compton P, et al. College on problems of drug dependence task force on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215232.
  • 9
    Chabal C, Erjavec MK, Jacobson L, Marravo A, EC. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain. 1997;13:150155.
  • 10
    Compton P, Darakjian MA, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16:355363.
  • 11
    Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440459.
  • 12
    Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:6575.
  • 13
    Robinson RC, Gatchel RJ, Polatin PB, Deschner M, Noe C. Screening for problematic prescription opioid use. Clin J Pain. 2001;17:220228.
  • 14
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561571.
  • 15
    Beck AT, Steer RA, Garbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77100.
  • 16
    Rissanen A, Alaranta H, Sainio P, Harkonen H. Isokinetic and non-dynamometric tests in low back pain patients related to pain and disability index. Spine. 1994;19:19631967.
  • 17
    Gatchel RJ, Mayer TG, Capra P, Diamond P, Barnett J. Quantification of lumbar function. Part 6: the use of psychological measures in guiding physical functional restoration. Spine. 1986;11:3642.
  • 18
    Million R, Haavik-Nilsen J, Jayson MIV, Baker RD. Evaluation of low back pain and assessment of lumbar corsets with and without back supports. Ann Rheum Dis. 1981; 40:449454.
  • 19
    Capra P, Mayer TG, Gatchel RJ. Adding psychological scales to your back pain assessment. J Musculoskelet Med. 1985;2:4152.
  • 20
    Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
  • 21
    Ware J. The MOS 36-item Short Form Health Survey (SF-36). In: SedererL, DickeyB, eds. Outcomes Assessment in Clinical Practice. Baltimore, MD: Williams & Wilkins; 1996.
  • 22
    Ware JE, Kosinski M, Turner-Bowker D, Gandek B. How to Score Version 2 of SF-12 Health Survey. Lincoln, RI: Quality Metric Incorporated; 2002.
  • 23
    Gatchel RJ. Clinical Essentials of Pain Management. Washington, DC: American Psychological Association; 2005.
  • 24
    Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271273.
  • 25
    Adams LL. The Development of a Self-Report Screening Instrument for Measuring Risks of Opioid Medication Misuse among a Heterogeneous Chronic Pain Population: The Pain Medication Questionnaire. Department of Psychiatry/Division of Psychology. Dallas, TX: The University of Texas Southwestern Medical Center at Dallas; 2002.
  • 26
    Leclaire R, Blier F, Fortin L, Proulx R. A cross-sectional study comparing the Oswestry and Roland-Morris functional disability scales in two populations of patients with low back pain of different levels of severity. Spine. 1997; 22:6871.
  • 27
    Strain EC. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin J Pain. 2002;18:S14S27.